TYBR Health raises $30 million Series A for B3 GEL System

Vensana Capital and Mutual Capital Partners co-led the round to expand commercial access, broaden indications and fund orthopedic surgery studies on tissue protection.

Summary

verifying reliability

Terms & Concepts

No specialized terms available for this topic.